Founder

Sourish Sen

Founder, Cytosomatic Labs

Cytosomatic Labs began with a straightforward observation: patients with neurodegenerative and complex neurological conditions are asked to accept blunt, symptomatic treatments in a decade where neural biology can be read with remarkable precision. The gap is not ambition — it is disciplined, well-documented execution.

I started this organization to build that discipline first: rigorous protocols, honest reporting of what is and is not validated, and a neuroscience research platform that partners can inspect rather than take on trust.

Sourish Sen, founder of Cytosomatic Labs

The founder's view

  1. 01Origin
  2. 02Investment
  3. 03Direction

01 — Origin

Built from a personal conviction.

Cytosomatic Labs was founded to take complex neurological conditions seriously at the cellular level.

02 — Investment

Backing long-horizon science.

The founder funds research that needs patience, rigour and a clear scientific rationale.

03 — Direction

Neuroscience at the centre.

Every decision is measured against one question: does this move neural medicine forward?

Operating principles

The convictions this organization is built on

Evidence before narrative

Every claim we publish traces back to a protocol, a dataset and a reviewer. Nothing is described as more mature than it is.

Patients define the problem

Neurodegenerative and complex neurological patients live with trade-offs that datasets rarely capture. Their experience sets our research priorities.

Open collaboration

Small teams move faster with good partners. We design our work so that academic and clinical groups can plug in early.

Build the boring layer well

Reproducibility, provenance and documentation are the substrate of credible science — not overhead to be optimised away.

Interested in working together?

I read every collaboration enquiry personally. Reach out through the contact form or connect with me directly on LinkedIn.